Open AccessOutpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres
Author(s) -
Abe Quast,
Vincent F. van Dijk,
Arthur A.M. Wilde,
Reinoud E. Knops,
Lucas Boersma
Publication year - 2017
Publication title -
netherlands heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.578
H-Index - 37
eISSN - 1876-6250
pISSN - 1568-5888
DOI - 10.1007/s12471-017-0957-4
Subject(s) - medicine , ejection fraction , implantable cardioverter defibrillator , implant , sudden cardiac death , defibrillation , emergency medicine , cardiology , heart failure , surgery
The latest European Society of Cardiology Guidelines recommend consideration of a wearable cardioverter-defibrillator (WCD) for patients with a poor left ventricular ejection fraction (LVEF) who are at risk of sudden arrhythmic death but are not eligible for an implantable defibrillator. For these patients a WCD can be an alternative to long-term hospitalisation.